QUOTE
DexCom, Inc. (DXCM)
$
10.99
 $0.06 (0.55%) Jan 26
|
5555 Oberlin Drive
,
San Diego,
CA
92121
,
USA
+1-858-200-0200
http://www.dexcom.com/ |
|
|
| PRICES |
| Open |
Volume |
| 10.98 |
434,000 |
| High |
Low |
| 11.06 |
10.63 |
|
| VALUATIONS |
| Mkt Cap |
Avg Volume |
| 682 |
1.90M |
| 52wk High |
52wk Low |
| 16.72 |
6.91 |
|
| RATIOS |
| P/E |
EPS |
| n/a |
n/a |
| BV |
P/BV |
| 0.98 |
11.21 |
|
| STOCKHOLDERS |
| Dividend |
Yield |
| n/a |
n/a |
| Shares |
Inst Owner |
| 62.08 |
|
|
|
|
|
PERFORMANCE
You need to upgrade your Flash Player
|
|
ANNUAL EARNINGS
You need to upgrade your Flash Player
|
|
QUARTERLY EARNINGS (EPS)
You need to upgrade your Flash Player
|
|
SUMMARIES CALENDARS REPORTS
|
|
| Financial Summary (In millions of USD)
|
| |
2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 |
| Income statement |
| Total Revenue |
- | - | - | $2.17 | $4.63 | $9.84 | $29.69 |
| Operating Income |
$-10.18 | $-14.07 | $-32.43 | $-49.32 | $-46.68 | $-52.83 | $-45.83 |
| Net Income |
$-9.91 | $-13.95 | $-30.77 | $-46.60 | $-45.88 | $-58.86 | $-53.52 |
| Balance Sheet |
| Total Assets |
$20.77 | $29.36 | $56.73 | $64.55 | $77.26 | $43.88 | $46.95 |
| Total Equity |
$19.78 | $27.66 | $49.41 | $56.83 | $7.12 | $-19.47 | $-18.45 |
| Total Liabilities |
$0.98 | $1.69 | $7.31 | $7.72 | $70.14 | $63.35 | $65.39 |
| Cash Flow |
| Operating |
$-9.46 | $-12.43 | $-22.55 | $-43.73 | $-33.21 | $-37.45 | $-39.39 |
| Investing |
$7.37 | $-1.74 | $-18.17 | $-26.56 | $-8.44 | $24.32 | $-14.10 |
| Financing |
$0.03 | $21.38 | $50.74 | $51.22 | $46.60 | $2.71 | $44.38 |
| Net Cash Change |
$-2.06 | $7.21 | $10.02 | $-19.08 | $4.95 | $-10.41 | $-9.12 |
|
Earning Call Calender
|
| 2010 | 2009 |
2008 |
2007 |
2006 |
09 March 2010
05 May 2010
03 August 2010
|
05 March 2009
06 May 2009
03 August 2009
04 November 2009
|
11 March 2008
08 May 2008
05 August 2008
10 November 2008
|
27 February 2007
09 May 2007
30 July 2007
30 July 2007
30 October 2007
|
| |
|
| Earning Call Summary |
Transcripts |
| |
|
| 10K Reports |
Annual Reports |
| |
| Ticker News
|
|
| |
Management
|
|
Executive |
Title |
|
Donald L. Lucas |
Chairman of the Board | |
|
Terrance H. Gregg |
President, Chief Executive Officer, Director |
|
Andrew K. Balo |
Sr. VP Regulatory, Clinical and Quality |
|
Jess Roper |
Chief Financial Officer and Vice President |
|
Steven R. Pacelli |
Senior Vice President - Corporate Affairs |
|
Jorge Valdes |
Senior Vice President - Operations |
|
Rodney Kellogg |
Vice President - Sales |
|
James H. Brauker |
Vice President of Research and Development |
|
|
|
Sources: Data collected by 123jump.com and Ticker.com from company press releases, filings and corporate websites. Market data: BATS Exchange. Inc
